• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.11% Nasdaq Down 0.06%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    8.30 Down 0.20(2.35%) 11:20AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.50
    Open:8.56
    Bid:8.34 x 200
    Ask:8.37 x 100
    1y Target Est:26.83
    Beta:-1.79
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:8.27 - 8.56
    52wk Range:5.92 - 22.55
    Volume:79,357
    Avg Vol (3m):710,937
    Market Cap:201.49M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RPRXDown 2.35%201.49M
    ABTDown 0.30%65.58B
    ACTDown 1.02%73.51B
    AUXLUp 1.22%1.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.38
    Quarterly EPS Est (Dec-14) :-0.31
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback